Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview

Ferenc Pakodi, Omar M E Abdel-Salam, Andras Debreceni, G. Mózsik

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Since the historical rediscovery of gastric spiral Helicobacter Pylori in the gastric mucosa of patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has been largely viewed as being of infectious aetiology. Indeed, there is a strong association between the presence of H. pylori and chronic active gastritis in histology. The bacterium can be isolated in not less than 70% of gastric and in over 90% of duodenal ulcer patients. Eradication of the organism has been associated with histologic improvement of gastritis, lower relapse rate and less risk of bleeding from duodenal ulcer. The bacterium possesses several virulence factors enabling it to survive the strong acid milieu inside the stomach and possibly damaging host tissues. The sequence of events by which the bacterium might cause gastric or duodenal ulcer is still not fully elucidated and Koch's postulates have never been fulfilled. In the majority of individuals, H. pylori infection is largely or entirely asymptomatic and there is no convincing data to suggest an increase in the prevalence of peptic ulcer disease among these subjects. An increasingly growing body of literature suggests an association between colonization by H. pylori in the stomach and a risk for developing gastric mucosa-associated lymphoid tissue (MALT), MALT lymphoma, gastric adenocarcinoma and even pancreatic adenocarcinoma. The bacterium has been implicated also in a number of extra-gastrointestinal disorders such as ischaemic heart disease, ischaemic cerebrovascular disease atherosclerosis, and skin diseases such as rosacea, but a causal role for the bacterium is missing. Eradication of H. pylori thus seems to be a beneficial impact on human health. Various drug regimens are in use to eradicate H. pylori involving the administration of three or four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole for 1-2 weeks. The financial burden, side effects and emergence of drug resistant strains due to an increase in the use in antibiotics for H. pylori eradication therapy need further reconsideration. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)139-152
Number of pages14
JournalJournal of Physiology Paris
Volume94
Issue number2
DOIs
Publication statusPublished - Mar 2000

Fingerprint

Helicobacter pylori
Bacteria
Stomach
Gastritis
Duodenal Ulcer
Gastric Mucosa
Peptic Ulcer
Adenocarcinoma
Rosacea
Cerebrovascular Disorders
Tetracyclines
Marginal Zone B-Cell Lymphoma
Bismuth
Ranitidine
Clarithromycin
Omeprazole
Amoxicillin
Metronidazole
Helicobacter Infections
Lymphoid Tissue

Keywords

  • Gastric cancer
  • Helicobacter pylori
  • MALT lymphoma
  • Peptic ulcer

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology (medical)

Cite this

Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. / Pakodi, Ferenc; Abdel-Salam, Omar M E; Debreceni, Andras; Mózsik, G.

In: Journal of Physiology Paris, Vol. 94, No. 2, 03.2000, p. 139-152.

Research output: Contribution to journalArticle

Pakodi, Ferenc ; Abdel-Salam, Omar M E ; Debreceni, Andras ; Mózsik, G. / Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. In: Journal of Physiology Paris. 2000 ; Vol. 94, No. 2. pp. 139-152.
@article{6993f579eead4d3f805b9de580fe37f6,
title = "Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview",
abstract = "Since the historical rediscovery of gastric spiral Helicobacter Pylori in the gastric mucosa of patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has been largely viewed as being of infectious aetiology. Indeed, there is a strong association between the presence of H. pylori and chronic active gastritis in histology. The bacterium can be isolated in not less than 70{\%} of gastric and in over 90{\%} of duodenal ulcer patients. Eradication of the organism has been associated with histologic improvement of gastritis, lower relapse rate and less risk of bleeding from duodenal ulcer. The bacterium possesses several virulence factors enabling it to survive the strong acid milieu inside the stomach and possibly damaging host tissues. The sequence of events by which the bacterium might cause gastric or duodenal ulcer is still not fully elucidated and Koch's postulates have never been fulfilled. In the majority of individuals, H. pylori infection is largely or entirely asymptomatic and there is no convincing data to suggest an increase in the prevalence of peptic ulcer disease among these subjects. An increasingly growing body of literature suggests an association between colonization by H. pylori in the stomach and a risk for developing gastric mucosa-associated lymphoid tissue (MALT), MALT lymphoma, gastric adenocarcinoma and even pancreatic adenocarcinoma. The bacterium has been implicated also in a number of extra-gastrointestinal disorders such as ischaemic heart disease, ischaemic cerebrovascular disease atherosclerosis, and skin diseases such as rosacea, but a causal role for the bacterium is missing. Eradication of H. pylori thus seems to be a beneficial impact on human health. Various drug regimens are in use to eradicate H. pylori involving the administration of three or four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole for 1-2 weeks. The financial burden, side effects and emergence of drug resistant strains due to an increase in the use in antibiotics for H. pylori eradication therapy need further reconsideration. (C) 2000 Elsevier Science Ltd.",
keywords = "Gastric cancer, Helicobacter pylori, MALT lymphoma, Peptic ulcer",
author = "Ferenc Pakodi and Abdel-Salam, {Omar M E} and Andras Debreceni and G. M{\'o}zsik",
year = "2000",
month = "3",
doi = "10.1016/S0928-4257(00)00160-1",
language = "English",
volume = "94",
pages = "139--152",
journal = "Journal de Physiologie",
issn = "0928-4257",
publisher = "Elsevier Masson SAS",
number = "2",

}

TY - JOUR

T1 - Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview

AU - Pakodi, Ferenc

AU - Abdel-Salam, Omar M E

AU - Debreceni, Andras

AU - Mózsik, G.

PY - 2000/3

Y1 - 2000/3

N2 - Since the historical rediscovery of gastric spiral Helicobacter Pylori in the gastric mucosa of patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has been largely viewed as being of infectious aetiology. Indeed, there is a strong association between the presence of H. pylori and chronic active gastritis in histology. The bacterium can be isolated in not less than 70% of gastric and in over 90% of duodenal ulcer patients. Eradication of the organism has been associated with histologic improvement of gastritis, lower relapse rate and less risk of bleeding from duodenal ulcer. The bacterium possesses several virulence factors enabling it to survive the strong acid milieu inside the stomach and possibly damaging host tissues. The sequence of events by which the bacterium might cause gastric or duodenal ulcer is still not fully elucidated and Koch's postulates have never been fulfilled. In the majority of individuals, H. pylori infection is largely or entirely asymptomatic and there is no convincing data to suggest an increase in the prevalence of peptic ulcer disease among these subjects. An increasingly growing body of literature suggests an association between colonization by H. pylori in the stomach and a risk for developing gastric mucosa-associated lymphoid tissue (MALT), MALT lymphoma, gastric adenocarcinoma and even pancreatic adenocarcinoma. The bacterium has been implicated also in a number of extra-gastrointestinal disorders such as ischaemic heart disease, ischaemic cerebrovascular disease atherosclerosis, and skin diseases such as rosacea, but a causal role for the bacterium is missing. Eradication of H. pylori thus seems to be a beneficial impact on human health. Various drug regimens are in use to eradicate H. pylori involving the administration of three or four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole for 1-2 weeks. The financial burden, side effects and emergence of drug resistant strains due to an increase in the use in antibiotics for H. pylori eradication therapy need further reconsideration. (C) 2000 Elsevier Science Ltd.

AB - Since the historical rediscovery of gastric spiral Helicobacter Pylori in the gastric mucosa of patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has been largely viewed as being of infectious aetiology. Indeed, there is a strong association between the presence of H. pylori and chronic active gastritis in histology. The bacterium can be isolated in not less than 70% of gastric and in over 90% of duodenal ulcer patients. Eradication of the organism has been associated with histologic improvement of gastritis, lower relapse rate and less risk of bleeding from duodenal ulcer. The bacterium possesses several virulence factors enabling it to survive the strong acid milieu inside the stomach and possibly damaging host tissues. The sequence of events by which the bacterium might cause gastric or duodenal ulcer is still not fully elucidated and Koch's postulates have never been fulfilled. In the majority of individuals, H. pylori infection is largely or entirely asymptomatic and there is no convincing data to suggest an increase in the prevalence of peptic ulcer disease among these subjects. An increasingly growing body of literature suggests an association between colonization by H. pylori in the stomach and a risk for developing gastric mucosa-associated lymphoid tissue (MALT), MALT lymphoma, gastric adenocarcinoma and even pancreatic adenocarcinoma. The bacterium has been implicated also in a number of extra-gastrointestinal disorders such as ischaemic heart disease, ischaemic cerebrovascular disease atherosclerosis, and skin diseases such as rosacea, but a causal role for the bacterium is missing. Eradication of H. pylori thus seems to be a beneficial impact on human health. Various drug regimens are in use to eradicate H. pylori involving the administration of three or four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole for 1-2 weeks. The financial burden, side effects and emergence of drug resistant strains due to an increase in the use in antibiotics for H. pylori eradication therapy need further reconsideration. (C) 2000 Elsevier Science Ltd.

KW - Gastric cancer

KW - Helicobacter pylori

KW - MALT lymphoma

KW - Peptic ulcer

UR - http://www.scopus.com/inward/record.url?scp=0034036843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034036843&partnerID=8YFLogxK

U2 - 10.1016/S0928-4257(00)00160-1

DO - 10.1016/S0928-4257(00)00160-1

M3 - Article

C2 - 10791696

AN - SCOPUS:0034036843

VL - 94

SP - 139

EP - 152

JO - Journal de Physiologie

JF - Journal de Physiologie

SN - 0928-4257

IS - 2

ER -